Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.326NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.558NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.518NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.368NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.404NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.306NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.328NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
A.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.533NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.525NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.480NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.15NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.24NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.236NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.153NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.302NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.194NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.55NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.51NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.308NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.138NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.379NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.240NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.240.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.121.1 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-4360.53China
B.1.1.46NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.44NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.389NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.549NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.160.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.214NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.304NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.214.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.577NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.639NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
A.2.5.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AZ.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.270NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.227NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
U.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.36.28NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.395NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.37NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.61NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.40NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.153NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.33NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.10NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.62NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used